2025-11-17 - LD Lisbon - Boehringer Ingelheim v. Zentiva - UPC_CFI_858/2025
- Aktenzeichen:
- UPC_CFI_858/2025
- Datum:
- Spruchkörper:
- Court of First Instance - Lisbon (PT) Local Division
- Art:
- Order
- Parteien:
- Boehringer Ingelheim International GMBH v. Zentiva Portugal, Lda.
Kernaussage: ENGLISH:
2025-11-17 - LD Lisbon - Boehringer Ingelheim
v.
Zentiva - UPC_CFI_858/2025
ENGLISH:
Preliminary objection pursuant to R. 19.1(a) RoP and R.20. 1 RoP
routine
The Lisbon LD rejected a preliminary objection challenging UPC jurisdiction in a threatened infringement action concerning nintedanib (EP 1,830,843). The defendant argued the dispute was administrative because the threat arose from an INFARMED communication. The court held the action was between private competitors under Art. 32(1)(a) UPCA — the regulatory communication was grounds for establishing the threat, not the dispute's basis. The merits argument (no actual infringing acts) was rejected as outside the exhaustive R. 19 RoP scope.
Stichwörter
ENGLISH: Preliminary objection